Revolution Medicines Inc (RVMD)
37.29
+0.18
(+0.49%)
USD |
NASDAQ |
Apr 30, 16:00
37.29
0.00 (0.00%)
After-Hours: 20:00
Revolution Medicines Cash from Operations (TTM): -350.57M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -350.57M |
September 30, 2023 | -291.80M |
June 30, 2023 | -243.04M |
March 31, 2023 | -231.63M |
December 31, 2022 | -224.40M |
September 30, 2022 | -201.88M |
June 30, 2022 | -186.73M |
March 31, 2022 | -165.09M |
December 31, 2021 | -147.18M |
Date | Value |
---|---|
September 30, 2021 | -132.95M |
June 30, 2021 | -123.38M |
March 31, 2021 | -109.29M |
December 31, 2020 | -100.06M |
September 30, 2020 | -86.68M |
June 30, 2020 | -73.52M |
March 31, 2020 | -65.03M |
December 31, 2019 | -49.62M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-350.57M
Minimum
Dec 2023
-49.62M
Maximum
Dec 2019
-163.70M
Average
-147.18M
Median
Dec 2021
Cash from Operations (TTM) Benchmarks
Cutera Inc | -137.64M |
BioSig Technologies Inc | -17.31M |
TRACON Pharmaceuticals Inc | 3.676M |
Zentalis Pharmaceuticals Inc | -207.82M |
Day One Biopharmaceuticals Inc | -146.85M |